前沿论文｜CELL INTELLIGENCE

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.

PubMed 2026/04/09 发表Nat CommunQ1 · IF 18.1（JCR 2025）

82.0分

★★★★☆

站内排序·非疗效

CAR-Based Cell and Gene Therapies: Global Clinical Landscape and Emerging Therapeutic Strategies from ClinicalTrials.gov.

PubMed 2025/10/27 发表Biomol Ther (Seoul)Q1 · IF 4.9（JCR 2025）

41.7分

★★☆☆☆

站内排序·非疗效

CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated.

PubMed 2023/04/19 发表Oncol LettQ3 · IF 2.1（JCR 2025）

31.6分

★☆☆☆☆

站内排序·非疗效

Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.

PubMed 2023/02/02 发表Best Pract Res Clin HaematolQ2 · IF 3.4（JCR 2025）

31.6分

★☆☆☆☆

站内排序·非疗效

前沿论文 4